{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:03Z","timestamp":1767134763403,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":73,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003462.pub2","type":"reference-entry","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T05:56:47Z","timestamp":1208757407000},"source":"Crossref","is-referenced-by-count":7,"title":["Heparin versus placebo for acute coronary syndromes"],"prefix":"10.1002","author":[{"given":"Kirk","family":"Magee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel G","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Moher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian H","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,4,23]]},"reference":[{"issue":"19","key":"10.1002\/14651858.CD003462.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0002-9149(90)91155-Y","article-title":"Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group)","volume":"66","author":"Cohen","year":"1990","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD003462.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","article-title":"Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users","volume":"89","author":"Cohen","year":"1994","journal-title":"Circulation"},{"issue":"9","key":"10.1002\/14651858.CD003462.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.101.9.955","article-title":"Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restoneosis after coronary artery angioplasty","volume":"101","author":"Doucet","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"25E","DOI":"10.1016\/S0002-9149(97)00486-4","article-title":"Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC)","volume":"80","author":"Swahn","year":"1997","journal-title":"American College of Cardiology"},{"issue":"9001","key":"10.1002\/14651858.CD003462.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","article-title":"Low-molecular-weight heparin during instability in coronary artery disease","volume":"347","author":"Wallentin","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003462.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0735-1097(95)80001-W","article-title":"Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia","volume":"26","author":"Gurfinkel","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD003462.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0735-1097(94)90539-8","article-title":"Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina","volume":"24","author":"Holdright","year":"1994","journal-title":"Journal of the American College of Cardiology"},{"issue":"8719","key":"10.1002\/14651858.CD003462.pub2-BIB8|cit8","first-page":"830","article-title":"Risk of myocardial infarction and death during treatment with low-dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","author":"Wallentin","year":"1990","journal-title":"Lancet"},{"issue":"17","key":"10.1002\/14651858.CD003462.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Theroux","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003462.pub2-BIB10|cit10","first-page":"4","article-title":"Unstable angina pectoris: aspirin and heparin in a double-blind placebo-controlled study, their effects on the outcojjme of disease during hospitalization","volume":"33","author":"Averkov","year":"1993","journal-title":"Kardiologiya"},{"issue":"2","key":"10.1002\/14651858.CD003462.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0735-1097(95)90035-7","article-title":"Heparin and aspirin in unstable angina: insufficeitn sample size may lead to erroneous conclusions","volume":"25","author":"Bodo","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"issue":"15","key":"10.1002\/14651858.CD003462.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0025-7753(00)71631-9","article-title":"Low molecular weigh heparin in the treatment of acute coronary syndromes without ST elevation: Unstable angina and non Q wave myocardial infaction","volume":"115","author":"Borja","year":"2000","journal-title":"Medicina Clinica"},{"issue":"8","key":"10.1002\/14651858.CD003462.pub2-BIB13|cit13","first-page":"1147","article-title":"Dalteparin in the acute phase of unstable angina and non-Q-wave infarction","volume":"53","author":"Borja","year":"2000","journal-title":"Revista Espanola de Cardiologia"},{"issue":"20","key":"10.1002\/14651858.CD003462.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1001\/archinte.160.20.3169-a","article-title":"Dalteparin for unstable angina and non-Q-wave myocardial infarction","volume":"160","author":"Borja","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003462.pub2-BIB15|cit15","first-page":"146","article-title":"Comparative study of heparin and antiplatelets in treatment of preinfarction angina","volume":"34","author":"Charvat","year":"1989","journal-title":"Cardiologia"},{"issue":"5","key":"10.1002\/14651858.CD003462.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0735-1097(93)90540-H","article-title":"Prospective comparison of unstable angina versus non-Q-wave myocardial infarction during antithrombotic therapy","volume":"22","author":"Cohen","year":"1993","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003462.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/jama.276.23.1873c","article-title":"Benefit of heparin plus aspirin vs aspirin alone in unstable angina","volume":"276","author":"Collins","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD003462.pub2-BIB18|cit18","first-page":"475","article-title":"The role of low molecular weight heparin in unstable angina, acute myocardial infarction and post-elective percutaneous transluminal coronary angioplast","volume":"65","author":"Correia","year":"1995","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"10.1002\/14651858.CD003462.pub2-BIB19|cit19","first-page":"74","article-title":"Preventing MI with heparin","volume":"June","year":"1989","journal-title":"Emergency Medicine"},{"key":"10.1002\/14651858.CD003462.pub2-BIB20|cit20","first-page":"533","article-title":"Low molecular weight heparin for treatment of acute myocardial infarction (FAMI): Fragmin (dalteparin sodium) in acute myocardial infarction","volume":"52","author":"Kakkar","year":"2000","journal-title":"Indian Heart Journal"},{"key":"10.1002\/14651858.CD003462.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003495-199958060-00002","article-title":"Platelet Glycoprotein IIb\/IIa receptor antagonists current concepts and future directions","volume":"58","author":"Gerguson","year":"1999","journal-title":"Drugs"},{"issue":"9180","key":"10.1002\/14651858.CD003462.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(99)07350-X","article-title":"Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","volume":"354","author":"Ragmin","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003462.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.77.5.1022","article-title":"Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina","volume":"77","author":"Fujita","year":"1988","journal-title":"Circulation"},{"issue":"8707","key":"10.1002\/14651858.CD003462.pub2-BIB24|cit24","first-page":"65","article-title":"GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction","volume":"336","author":"Feruglio","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003462.pub2-BIB25|cit25","first-page":"229","article-title":"Heparin in myocardial infarction and unstable angina","volume":"38","author":"Gorski","year":"1993","journal-title":"Kardiologia Polska"},{"key":"10.1002\/14651858.CD003462.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0140-6736(99)00264-0","article-title":"Contemporary approach to management of unstable angina","volume":"354","author":"Goy","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD003462.pub2-BIB27|cit27","first-page":"35","article-title":"Heparin therapy in coronary heart disease","volume":"117","author":"Gulba","year":"1992","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"1","key":"10.1002\/14651858.CD003462.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0272989X9801800110","article-title":"Meta-analysis of multitreatment studies","volume":"18","author":"Hasselblad","year":"1998","journal-title":"Medical Decision Making"},{"key":"10.1002\/14651858.CD003462.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0049-3848(89)90308-3","article-title":"Heparin induced increase of T-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatment","volume":"55","author":"Huber","year":"1989","journal-title":"Thrombosis Research"},{"issue":"5","key":"10.1002\/14651858.CD003462.pub2-BIB30|cit30","first-page":"463","article-title":"Acute myocardial infarction treated with anticoagulants","volume":"54","author":"Hurtado","year":"1984","journal-title":"Archivos del Instituto de Cardiologia de Mexico"},{"key":"10.1002\/14651858.CD003462.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0002-8703(93)90688-6","article-title":"Therapeutic approach to unstable angina: nitroglycerin, heparin, and combined therapy","volume":"126","author":"Jaffrani","year":"1993","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD003462.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0735-1097(00)00648-3","article-title":"Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin","volume":"35","author":"Kaul","year":"2000","journal-title":"Journal of the American College of Cardiology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003462.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"I3","DOI":"10.1002\/clc.4960241303","article-title":"Improving outcomes in acute coronary syndromes - the FRISC II trial","volume":"24","author":"Kontny","year":"2001","journal-title":"Clinical Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD003462.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/clc.4960220310","article-title":"Efficacy and tolerability of a very low molecular weight heparin compared with standard heparin in patients with unstable angina: a pilot study","volume":"22","author":"Mattioli","year":"1999","journal-title":"Clinical Cardiology"},{"key":"10.1002\/14651858.CD003462.pub2-BIB35|cit35","first-page":"433","volume":"8","author":"Millonig-Gannjer","year":"1989","journal-title":"Arch Medici Nr"},{"key":"10.1002\/14651858.CD003462.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/circ.90.2.8044926","article-title":"Aspirin versus heparin in the acute phase of unstable angina","volume":"90","author":"Moise","year":"1994","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(95)91294-0","article-title":"Heparin in unstable angina","volume":"346","author":"Montgomery","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003462.pub2-BIB38|cit38","first-page":"171","article-title":"Study on the efficacy of heparin and aspirin in unstable angina and acute heart infarction","volume":"10","author":"Nardelli","year":"1991","journal-title":"Clinica e Terapia Cardiovascolare"},{"key":"10.1002\/14651858.CD003462.pub2-BIB39|cit39","first-page":"222","article-title":"Low molecular weight heparin in unstable angina pectoris","volume":"69","author":"Ocampo","year":"1999","journal-title":"Archivos del Instituto de Cardiologia de Mexico"},{"key":"10.1002\/14651858.CD003462.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarctionand death in patients with unstable angina","volume":"276","author":"Oler","year":"1996","journal-title":"JAMA"},{"issue":"23","key":"10.1002\/14651858.CD003462.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1161\/hc4801.100358","article-title":"Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb\/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb\/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial","volume":"104","author":"Lauer","year":"2001","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7326\/0003-4819-119-9-199311010-00002","article-title":"The weight-based heparin dosing nomogram compared with a \"standard care\" nomogram","volume":"119","author":"Raschke","year":"1993","journal-title":"Annals of Internal Medicine"},{"issue":"16","key":"10.1002\/14651858.CD003462.pub2-BIB43|cit43","first-page":"638","article-title":"Low-molecular-weight heparins in unstable angina and non-Q-wave myocardial infarction","volume":"116","author":"Rubio-Terres","year":"2001","journal-title":"Medicina Clinica"},{"key":"10.1002\/14651858.CD003462.pub2-BIB44|cit44","first-page":"141","article-title":"Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units\/day) in the treatment of patients with acute coronary event - first year and long-term cmparative mortality","volume":"94","author":"Sayen","year":"1982","journal-title":"Transactions of the American Clinical & Climatological Association"},{"key":"10.1002\/14651858.CD003462.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-8703(88)90518-2","article-title":"Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin: a controlled cross-over randomized study","volume":"115","author":"Serneri","year":"1988","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD003462.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0140-6736(90)90407-V","article-title":"Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in regractory unstalbe angina","volume":"335","author":"Serneri","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003462.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0140-6736(95)91990-2","article-title":"Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group","volume":"345","author":"Serneri","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003462.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM198904133201515","article-title":"Aspirin, heparin, or both to treat unstable angina","volume":"320","author":"Spodick","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003462.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1026543107533","article-title":"The TETAMI Trial: the safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute myocardial infarction for patients not thrombolyzed: methods and design","volume":"10","author":"Cohen","year":"2000","journal-title":"Journal of Thrombosis & Thrombolysis"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD003462.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.88.5.2045","article-title":"Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina","volume":"88","author":"Theroux","year":"1993","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub2-BIB51|cit51","first-page":"88","article-title":"Management of unstable angina pectoris with maximal medical treatment (combination of intravenous nitrates, beta-blockers, calcium antagonists and heparin)","volume":"39","author":"Thieuleux","year":"1985","journal-title":"Bibliotheca Cardiologica"},{"key":"10.1002\/14651858.CD003462.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(05)64172-4","article-title":"The CAPTURE trial","volume":"350","author":"Umans","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003462.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0140-6736(91)93423-7","article-title":"Low-dose aspirin and heparin in ujnstable coronary artery disease","volume":"337","author":"Violaris","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003462.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"61E","DOI":"10.1016\/S0002-9149(97)00493-1","article-title":"Long-term low-molecular-weight heparin (Fragmin) and\/or early revascularization during instability in coronary artery disease (the FRISC II study)","volume":"80","author":"Wallentin","year":"1997","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003462.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0002-8703(91)90456-R","article-title":"Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina","volume":"122","author":"Wallis","year":"1991","journal-title":"American Heart Journal"},{"issue":"Suppl IV","key":"10.1002\/14651858.CD003462.pub2-BIB56|cit56","first-page":"IV","article-title":"Heparin in the treatment of unstable angina: a randomized prospective trial","volume":"76","author":"Zwerner","year":"1987","journal-title":"Circulation"},{"issue":"Suppl I","key":"10.1002\/14651858.CD003462.pub2-BIB57|cit57","first-page":"172","article-title":"ACLS. Part 7: the era of reperfusion. Section 1: acute coronary syndromes (acute myocardial infarction).","volume":"102","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.102.10.1193","article-title":"ACC\/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation of myocardial infarction. Executive summary and recommendations: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)","volume":"102","author":"Braunwald","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003462.pub2-BIB59|cit59","first-page":"239","article-title":"One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or chest pain in Hamilton, Ontario, a city of 375,000 people","volume":"319","author":"Cairns","year":"1989","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD003462.pub2-BIB60|cit60","article-title":"Assessment of study quality. Cochrane Reviewers Handbook 4.1.3 [updated june 2001]; Section 6","volume-title":"Cochrane Reviewers Handbook","author":"Clarke","year":"2001"},{"issue":"Suppl E","key":"10.1002\/14651858.CD003462.pub2-BIB61|cit61","first-page":"11E","article-title":"Approaches to the treatment of unstable angina and non-Q wave myocardial infarction","volume":"14","author":"Cohen","year":"1998","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD003462.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003462.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular weight heparin in acute coronary syndrome without ST elevation: a meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003462.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"24C","DOI":"10.1016\/S0002-9149(99)80467-6","article-title":"Elucidation of the role of plaque instability and rupture in acute coronary events","volume":"76","author":"Fuster","year":"1995","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003462.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003462.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"489S","DOI":"10.1378\/chest.114.5_Supplement.489S","article-title":"Heparin and low molecular weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"},{"key":"10.1002\/14651858.CD003462.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD003462.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD003462.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Proctective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results fo a Veterans Administration Cooperative Study","volume":"309","author":"Lewis","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003462.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD003462.pub2-BIB71|cit71","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002132","article-title":"Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes (Cochrane Review)","author":"Magee","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003462.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low molecular wieght heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003462.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.289.3.331","article-title":"Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention","volume":"289","author":"Wong","year":"2003","journal-title":"Journal of the American Medical Association"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003462.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T00:00:00Z","timestamp":1403827200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003462.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:21:02Z","timestamp":1628529662000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003462.pub2"}},"subtitle":[],"editor":[{"given":"Kirk","family":"Magee","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,4,23]]},"references-count":73,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003462.pub2","relation":{},"subject":[],"published":{"date-parts":[[2008,4,23]]}}}